NEWS

NEWS TYPE
RELEASE YEAR

EVENT

[Open Seminar] Harvey Lodish, Ph.D.

June 19, 2024

June 19, 2024

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar as follows:

Date & Time Wednesday, June 12, 2024, 16:00 -17:30
Venue  (Hybrid)  1F Lounge, Center for Integrated Medical Research, Shinanomachi Campus, Keio University and on zoom
Title New Technologies and Building Successful Biotechnology Companies to Treat Disease: A Personal History
Speaker Harvey F. Lodish, Ph.D.
Professor of Biology and Professor of Biological Engineering, Massachusetts Institute of Technology (USA)
Lead author, “Molecular Cell Biology”
Founder/scientific board member: Genzyme, Millennium Pharmaceuticals, Rubius Therapeutics, Tevard
Language English

Prof. Lodish highlighted the connection between academia and entrepreneurship in biotechnology, covering key aspects of starting a biotech company, intellectual property, and assembling a team with diverse expertise. The importance of scientists leveraging their expertise by consulting for or founding companies and the advantage of research institutes being located near biotech companies for collaboration was also discussed.

More Bio2Q News

EVENT
2025.07.17

【Seminar】WPI-Bio2Q Open Seminar: Jianguo Xia, Ph.D.

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event for faculty, ...

EVENT
2025.07.17

【Seminar】The 169th Brain Club Seminar-WPI-Bio2Q Open Seminar-

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event for faculty, ...

RESEARCH
2025.07.11

[Publication] Brain-wide mapping of immune receptors uncovers a neuromodulatory ...

This work reveals that immune molecules actively shape brain circuits, challenging the idea they only appear in disease and shedding light o...

RESEARCH
2025.07.11

[Publication] Emerging sensitivity to talking mouth in infants with low and elev...

This study shows that infants at higher risk for autism spectrum disorders pay less attention to talking mouths, a key cue for social develo...

RESEARCH
2025.07.11

[Publication] Microbiota-dependent modulation of intestinal anti-inflammatory CD...

This review, co-authored by a Bio2Q researcher, shows how gut microbes actively shape immunity and highlights new therapies like engineered ...